Developer docs
API playgroundTry for free, no card

Search company profiles

Stève Consultants

Full company profile

uuid000k44f

Namestring
Stève Consultants
Legal namestring
stève consultants
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Stève Consultants is a France-based B2B consulting firm specializing in market access, health economics and outcomes research (HEOR), and real-world evidence (RWE) for health products. Founded approximately 2004-2005 and headquartered in Oullins (Lyon area) with a Paris office, the firm has accumulated nearly two decades of experience supporting pharmaceutical, biotechnology, and medical device companies in obtaining and maintaining reimbursement for medications, vaccines, in-vitro diagnostics, and digital health solutions in France. The company tracks 750+ dossiers submitted to the Haute Autorité de Santé (HAS), 50+ economic model developments, 20+ HEOR evaluations, and 150+ RWE studies.

The firm operates three integrated service pillars: Market Access (pricing and reimbursement strategy, early access programs, HTA interactions with HAS, EU Joint Clinical Assessment support), HEOR (economic model development, efficiency dossiers for CEESP, international model adaptation), and RWE (epidemiological and pharmaco-epidemiological studies using the SNDS database linked with clinical registries, primary data, and clinical trials). Its underlying technology leverages statistical and machine learning methods including propensity scores, matching algorithms, predictive models, random forest, clustering, and treatment sequence analysis to extract insights from French national health data.

Stève Consultants generates revenue through professional services engagements priced on a quote basis, with no publicly disclosed pricing or standardized rate cards. The go-to-market is expert-led, relying on direct B2B engagement, industry event presence (e.g., ISPOR), thought leadership content via the Cytel platform, and referrals. The company is now a wholly-owned subsidiary of Cytel, integrated into the global clinical research and analytics organization while maintaining its French offices and customer relationships.

Short descriptiontext

French health consulting firm providing market access, HEOR, and real-world evidence services to pharmaceutical, biotechnology, and medical device companies seeking reimbursement and market entry in France. Operates as part of Cytel.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersOullins, France
HQ citystring
Oullins
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
market access consulting, health economics research, real-world evidence, pharmaceutical reimbursement, HEOR services
Industry5 codes
PRIMARYHLAGAAAK
Real-World Evidence (RWE), HEOR & Epidemiology CROs
SECONDARYHLAIAKAB
Health Economics & Outcomes Research (HEOR)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAIAKAA
Pricing & Contracting Strategy
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAIALAI
Real-World Evidence (RWE) & HEOR for Development
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAOAN
Market Access, Pricing & Reimbursement (Evidence Generation) FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code1 code
  • Management Consulting Services54161
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Pharmaceutical Market Access Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Market Access Consulting
TypeProfessional Services
Description

Strategic consulting services for pricing and reimbursement strategies in France, including dossier preparation for HAS, early access programs, and interactions with health authorities.

cytel.com
2HEOR Services
TypeProfessional Services
Description

Health Economics and Outcomes Research services including efficiency dossiers for CEESP, economic model development, scientific communications, and international model adaptation to French context.

cytel.com
3Real-World Evidence Studies
TypeProfessional Services
Description

Epidemiological and pharmaco-epidemiological studies using SNDS database for descriptive epidemiology, real-world effectiveness, clinical practices, and medico-economic analyses.

cytel.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Stève Consultants provides market access consulting, health economics and outcomes research (HEOR), and real-world evidence (RWE) studies for pharmaceutical, biotech, and medical device companies seeking reimbursement and market entry in France. Services include HAS dossier preparation, pricing and reimbursement strategy, economic model development, CEESP efficiency dossiers, epidemiological studies using the SNDS database, and EU Joint Clinical Assessment (EU-JCA) support.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 750+ dossiers submitted to HAS across medications, biotech, and medical devices
+3 more records
Product overview1 text field

Stève Consultants, part of Cytel, is a French market access consultancy offering three integrated service pillars: Market Access (pricing/reimbursement strategy and HTA interactions), Health Economics and Outcomes Research (HEOR) including economic modeling and CEESP dossiers, and Real-World Evidence (RWE) studies using the SNDS database. The services are designed to work together to support health product reimbursement in France, with capabilities for both local French projects and international multi-country studies.

Product and service4 records
1Market Access Services
CategoryMarket Access Consulting
Description

Strategic consulting for local pricing and reimbursement strategies, early access programs for innovative medications, and HTA interactions with French health authorities (HAS) including dossier preparation and committee meetings. Targeted at pharmaceutical, biotech, and medical device manufacturers seeking market entry and reimbursement in France.

2Health Economics and Outcomes Research (HEOR)
CategoryHealth Economics Consulting
Description

Development and adaptation of economic models, efficiency dossiers for French authorities (CEESP), scientific communications, and international model adaptation to the French context to support pricing and reimbursement positioning.

3Real-World Evidence (RWE)
CategoryReal-World Evidence Research
Description

Epidemiological and pharmaco-epidemiological studies using the French SNDS database (DCIR, ESND, PMSI) combined with clinical data sources, supporting market access strategy through data on patient characteristics, treatment patterns, and healthcare consumption.

4EU Joint Clinical Assessment (EU-JCA) Support
CategoryEuropean HTA Support
Description

Local contributions aligned with payer requirements for international market access strategy, with collaboration across European teams to support EU-JCA preparation for health products entering European markets.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Stève Consultants was acquired and integrated into Cytel, becoming part of Cytel's global network of strategic consulting services. This integration combines Stève's local French market expertise with Cytel's international reach, enabling clients to access both local market knowledge and global clinical trial and analytics capabilities.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large multi-country HEOR, RWE, and market access consultancy (now part of Thermo Fisher/PPRD) offering broader service portfolio than Stève. Broader incumbent competing for the same pharma/biotech HEOR and RWE mandates.

TypeDirect peer
Description

US-based RWE/HEOR research organization serving pharma, biotech, and medical device clients globally with health economics, real-world data, and market access services. Direct competitor on RWE generation and HEOR modeling for global pharma accounts.

3LASER Analytica
TypeDirect peer
Description

European HEOR, market access, and RWE consultancy headquartered in France. Comparable to Stève via shared SNDS exploitation, HAS dossier services, and pharma/biotech client base across therapeutic areas.

TypeDirect peer
Description

French HEOR, market access, and pharmaco-epidemiology consultancy serving pharma, medtech, and public health stakeholders. Highly comparable to Stève as a French-headquartered competitor with overlapping dossiers, HAS submissions, and SNDS/RWE expertise.

TypeEmerging player
Description

Specialized HEOR and market access consultancy with growing European footprint. Comparable positioning to Stève in providing economic models and HTA support, though smaller and more recent in the French market.

TypeBroad incumbent
Description

Global CRO with a market access and HEOR consulting arm serving pharma and biotech. Broader-scope incumbent that overlaps with Stève on HEOR models, RWE, and HTA dossier work.

TypeBroad incumbent
Description

Global CRO and healthcare data giant with a dedicated Real World Solutions practice delivering HEOR, market access, and large-scale RWE. Broad incumbent whose France team competes head-to-head with Stève.

TypeDirect peer
Description

Global HEOR, market access, and RWE consultancy founded in Paris, providing health economics modeling, HTA submissions, and real-world studies across Europe. Direct competitor to Stève in French market access and economic dossier delivery.

TypeDirect peer
Description

French consultancy advising life sciences clients on market access, HEOR, and health technology assessment. Closely comparable niche operator targeting pharma, biotech, and medtech with reimbursement support in France.

TypeDirect peer
Description

International consultancy with a France-based life sciences practice providing market access and HEOR services to pharma and medical device companies. Overlaps with Stève on French market access strategy and economic evaluations.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Stève Consultants

Pharmaceutical Market Access Consultingsteve-consultants.com

French health consulting firm providing market access, HEOR, and real-world evidence services to pharmaceutical, biotechnology, and medical device companies seeking reimbursement and market entry in France. Operates as part of Cytel.

What Stève Consultants does

Stève Consultants is a France-based B2B consulting firm specializing in market access, health economics and outcomes research (HEOR), and real-world evidence (RWE) for health products. Founded approximately 2004-2005 and headquartered in Oullins (Lyon area) with a Paris office, the firm has accumulated nearly two decades of experience supporting pharmaceutical, biotechnology, and medical device companies in obtaining and maintaining reimbursement for medications, vaccines, in-vitro diagnostics, and digital health solutions in France. The company tracks 750+ dossiers submitted to the Haute Autorité de Santé (HAS), 50+ economic model developments, 20+ HEOR evaluations, and 150+ RWE studies.

The firm operates three integrated service pillars: Market Access (pricing and reimbursement strategy, early access programs, HTA interactions with HAS, EU Joint Clinical Assessment support), HEOR (economic model development, efficiency dossiers for CEESP, international model adaptation), and RWE (epidemiological and pharmaco-epidemiological studies using the SNDS database linked with clinical registries, primary data, and clinical trials). Its underlying technology leverages statistical and machine learning methods including propensity scores, matching algorithms, predictive models, random forest, clustering, and treatment sequence analysis to extract insights from French national health data.

Stève Consultants generates revenue through professional services engagements priced on a quote basis, with no publicly disclosed pricing or standardized rate cards. The go-to-market is expert-led, relying on direct B2B engagement, industry event presence (e.g., ISPOR), thought leadership content via the Cytel platform, and referrals. The company is now a wholly-owned subsidiary of Cytel, integrated into the global clinical research and analytics organization while maintaining its French offices and customer relationships.

Stève Consultants firmographics

Firmographics
Name
Stève Consultants
Legal name
stève consultants
Website
https://steve-consultants.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
French health consulting firm providing market access, HEOR, and real-world evidence services to pharmaceutical, biotechnology, and medical device companies seeking reimbursement and market entry in France. Operates as part of Cytel.
Ownership category
akta.pro rank

Stève Consultants industry classification

Industry
Product category
Pharmaceutical Market Access Consulting
NAICS
Management Consulting Services (54161)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYHLAGAAAK
Real-World Evidence (RWE), HEOR & Epidemiology CROs
SECONDARYHLAIAKAB
Health Economics & Outcomes Research (HEOR)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAIAKAA
Pricing & Contracting Strategy
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAIALAI
Real-World Evidence (RWE) & HEOR for Development
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAOAN
Market Access, Pricing & Reimbursement (Evidence Generation) FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Market access consulting
  • Health economics research
  • Real-world evidence
  • Pharmaceutical reimbursement
  • HEOR services

Where Stève Consultants is headquartered

Location

Headquarters

HQ city
Oullins
HQ country
France
HQ region
Europe

Offices2 records

Markets served

Stève Consultants business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Market Access Consulting: Strategic consulting services for pricing and reimbursement strategies in France, including dossier preparation for HAS, early access programs, and interactions with health authorities.
  2. HEOR Services: Health Economics and Outcomes Research services including efficiency dossiers for CEESP, economic model development, scientific communications, and international model adaptation to French context.
  3. Real-World Evidence Studies: Epidemiological and pharmaco-epidemiological studies using SNDS database for descriptive epidemiology, real-world effectiveness, clinical practices, and medico-economic analyses.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Stève Consultants product offering

Product offering

Core offering

Stève Consultants provides market access consulting, health economics and outcomes research (HEOR), and real-world evidence (RWE) studies for pharmaceutical, biotech, and medical device companies seeking reimbursement and market entry in France. Services include HAS dossier preparation, pricing and reimbursement strategy, economic model development, CEESP efficiency dossiers, epidemiological studies using the SNDS database, and EU Joint Clinical Assessment (EU-JCA) support.

Product overview

Stève Consultants, part of Cytel, is a French market access consultancy offering three integrated service pillars: Market Access (pricing/reimbursement strategy and HTA interactions), Health Economics and Outcomes Research (HEOR) including economic modeling and CEESP dossiers, and Real-World Evidence (RWE) studies using the SNDS database. The services are designed to work together to support health product reimbursement in France, with capabilities for both local French projects and international multi-country studies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Market Access Services Strategic consulting for local pricing and reimbursement strategies, early access programs for innovative medications, and HTA interactions with French health authorities (HAS) including dossier preparation and committee meetings. Targeted at pharmaceutical, biotech, and medical device manufacturers seeking market entry and reimbursement in France.
  • Health Economics and Outcomes Research (HEOR) Development and adaptation of economic models, efficiency dossiers for French authorities (CEESP), scientific communications, and international model adaptation to the French context to support pricing and reimbursement positioning.
  • Real-World Evidence (RWE) Epidemiological and pharmaco-epidemiological studies using the French SNDS database (DCIR, ESND, PMSI) combined with clinical data sources, supporting market access strategy through data on patient characteristics, treatment patterns, and healthcare consumption.
  • EU Joint Clinical Assessment (EU-JCA) Support Local contributions aligned with payer requirements for international market access strategy, with collaboration across European teams to support EU-JCA preparation for health products entering European markets.

Quantifiable outcome

  • 750+ dossiers submitted to HAS across medications, biotech, and medical devices
  • +3 more outcomes

Companies that use Stève Consultants

Customer profile

Segments4 records

Ideal customer profiles3 records

Stève Consultants technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Stève Consultants partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • CytelcoreStrategic or Co-development PartnerStève Consultants was acquired and integrated into Cytel, becoming part of Cytel's global network of strategic consulting services. This integration combines Stève's local French market expertise with Cytel's international reach, enabling clients to access both local market knowledge and global clinical trial and analytics capabilities.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Stève Consultants competitors and assessment

Company assessment

Broad incumbents

  • Evidera: Large multi-country HEOR, RWE, and market access consultancy (now part of Thermo Fisher/PPRD) offering broader service portfolio than Stève. Broader incumbent competing for the same pharma/biotech HEOR and RWE mandates.
  • Parexel (Market Access Consulting): Global CRO with a market access and HEOR consulting arm serving pharma and biotech. Broader-scope incumbent that overlaps with Stève on HEOR models, RWE, and HTA dossier work.
  • IQVIA Real World Solutions: Global CRO and healthcare data giant with a dedicated Real World Solutions practice delivering HEOR, market access, and large-scale RWE. Broad incumbent whose France team competes head-to-head with Stève.

Direct peers

  • RTI Health Solutions: US-based RWE/HEOR research organization serving pharma, biotech, and medical device clients globally with health economics, real-world data, and market access services. Direct competitor on RWE generation and HEOR modeling for global pharma accounts.
  • LASER Analytica: European HEOR, market access, and RWE consultancy headquartered in France. Comparable to Stève via shared SNDS exploitation, HAS dossier services, and pharma/biotech client base across therapeutic areas.
  • CEMKA Eval: French HEOR, market access, and pharmaco-epidemiology consultancy serving pharma, medtech, and public health stakeholders. Highly comparable to Stève as a French-headquartered competitor with overlapping dossiers, HAS submissions, and SNDS/RWE expertise.
  • Creativ-Ceutical: Global HEOR, market access, and RWE consultancy founded in Paris, providing health economics modeling, HTA submissions, and real-world studies across Europe. Direct competitor to Stève in French market access and economic dossier delivery.
  • NEXTEP: French consultancy advising life sciences clients on market access, HEOR, and health technology assessment. Closely comparable niche operator targeting pharma, biotech, and medtech with reimbursement support in France.
  • Amaris Consulting (Market Access & HEOR): International consultancy with a France-based life sciences practice providing market access and HEOR services to pharma and medical device companies. Overlaps with Stève on French market access strategy and economic evaluations.

Emerging players

  • Maple Health Group: Specialized HEOR and market access consultancy with growing European footprint. Comparable positioning to Stève in providing economic models and HTA support, though smaller and more recent in the French market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Stève Consultants social profiles

Digital presence

Stève Consultants financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Stève Consultants leadership team

Management profile

Number of profiles

Profiles5 records

Stève Consultants funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Stève Consultants M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stève Consultants

What does Stève Consultants do?

Stève Consultants provides market access consulting, health economics and outcomes research (HEOR), and real-world evidence (RWE) studies for pharmaceutical, biotech, and medical device companies seeking reimbursement and market entry in France. Services include HAS dossier preparation, pricing and reimbursement strategy, economic model development, CEESP efficiency dossiers, epidemiological studies using the SNDS database, and EU Joint Clinical Assessment (EU-JCA) support.

Is Stève Consultants a public or private company?

Stève Consultants is a private company. It is classified as corporate owned and is currently operating.

When was Stève Consultants founded?

Stève Consultants was founded in 2006. It employs 11 to 50 people.

Where is Stève Consultants based?

Stève Consultants is headquartered in Oullins, France, in the Europe region.

How does Stève Consultants make money?

Three revenue lines are on record. Market Access Consulting is the primary driver. The others are HEOR Services and real-World Evidence Studies.

Who are Stève Consultants's main competitors?

Broad incumbents on record are Evidera, Parexel (Market Access Consulting) and IQVIA Real World Solutions. Direct peers are RTI Health Solutions, LASER Analytica, CEMKA Eval, Creativ-Ceutical, NEXTEP and Amaris Consulting (Market Access & HEOR). Maple Health Group is listed as an emerging player.

Does Stève Consultants have an API?

No public API is recorded for Stève Consultants.

What industry is Stève Consultants in?

Stève Consultants's product category is Pharmaceutical Market Access Consulting. Its primary akta.pro industry code is HLAGAAAK, Real-World Evidence (RWE), HEOR & Epidemiology CROs, with a secondary code of HLAIAKAB, Health Economics & Outcomes Research (HEOR). Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals